Adam Bagg

22.0k citations
216 papers · 11.9k indexed · 5 hit papers · h-index 37

Impact in

  • Oncology top 0.2%
    • CAR-T cell therapy research
  • Hematology top 0.5%
    • Acute Myeloid Leukemia Research

Papers in

    • Chronic Lymphocytic Leukemia Research 58
    • Myeloproliferative Neoplasms: Diagnosis and Treatment 32
    • Acute Myeloid Leukemia Research 68
    • Chronic Myeloid Leukemia Treatments 23

Adam Bagg

205 papers receiving 11.6k citations

Hit Papers

Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia 2015 · 1.3k citations
1.3k200320262010201850010001.5k2.0k2.5k

Peers

Adam Bagg
Comparison fields: 5 of 142
  • Oncology 7.0k
  • Hematology 2.0k
  • Genetics 1.7k
  • Immunology 3.2k
  • Genetics 2.9k
Replace David T. Teachey with:
David T. Teachey United States
Sattva S. Neelapu United States
Partow Kebriaei United States
Maryalice Stetler‐Stevenson United States
Mariusz A. Wasik United States
Stephen J. Schuster United States
Katayoun Rezvani United States
David L. Porter United States
Stephen Gottschalk United States
Cameron J. Turtle United States
Adam Bagg relative to David T. Teachey United States David T. Teachey's profile →
Citations per field
00.5×1.5×1.8×
David T. Teachey · 1×
Citations per year

Countries citing papers authored by Adam Bagg

Since Specialization
Citations

This map shows the geographic impact of Adam Bagg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Bagg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Bagg more than expected).

Fields of papers citing papers by Adam Bagg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam Bagg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Bagg. The network helps show where Adam Bagg may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Adam Bagg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Adam Bagg Line = papers co-authored together Adam Bagg links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20241
2 20246
3 20242
4 20240
5 20234
6 20231
7 202316
8 20224
9 20212
10 202125
11 20202
12 202022
13 20208
14 201925
15 201829
16 201713
17 20176
18 200829
19 200796
20 2003113

About Adam Bagg

Adam Bagg is a scholar working on Genetics, Hematology, Pathology and Forensic Medicine, Oncology and Rheumatology, having authored 216 papers that have together received 11.9k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (82 papers), Acute Myeloid Leukemia Research (68 papers), Chronic Lymphocytic Leukemia Research (58 papers), Viral-associated cancers and disorders (34 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (32 papers), Chronic Myeloid Leukemia Treatments (23 papers), Acute Lymphoblastic Leukemia research (20 papers) and Eosinophilic Disorders and Syndromes (19 papers). The work is most often cited by research in Oncology (7.0k citations), Hematology (2.0k citations), Genetics (1.7k citations), Immunology (3.2k citations) and Genetics (2.9k citations). Adam Bagg has collaborated with scholars based in United States, Canada and South Africa. Frequent co-authors include Carl H. June, Bruce L. Levine, David L. Porter, Michael Kalos, Stephan A. Grupp, Sharyn I. Katz, James M. Wilson, Guangping Gao, Narendra Chirmule and Frank S. Lee. Their work appears in journals such as Blood, American Journal of Clinical Pathology, Modern Pathology, Journal of Molecular Diagnostics and American Journal of Hematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026